{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:20:48Z","timestamp":1761744048475},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2014,11,6]],"date-time":"2014-11-06T00:00:00Z","timestamp":1415232000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0111544","type":"journal-article","created":{"date-parts":[[2014,11,6]],"date-time":"2014-11-06T19:21:54Z","timestamp":1415301714000},"page":"e111544","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Rapid and Simultaneous Quantification of Levetiracetam and Its Carboxylic Metabolite in Human Plasma by Liquid Chromatography Tandem Mass Spectrometry"],"prefix":"10.1371","volume":"9","author":[{"given":"Li-Ling","family":"Yeap","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoke-Lin","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,11,6]]},"reference":[{"key":"ref1","unstructured":"(2011) Keppra: Prescribing Information [Product Insert]. Smyrna, GA: UCB."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0163-7258(99)00052-2","article-title":"Pharmacokinetic profile of levetiracetam: toward ideal characteristics","volume":"85","author":"PN Patsalos","year":"2000","journal-title":"Pharmacol Ther"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1358\/mf.2003.25.2.723686","article-title":"The pharmacokinetic characteristics of levetiracetam","volume":"25","author":"PN Patsalos","year":"2003","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2165\/00003088-200443110-00002","article-title":"Clinical pharmacokinetics of levetiracetam","volume":"43","author":"PN Patsalos","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1111\/j.1528-1167.2006.00819.x","article-title":"In situ metabolism of levetiracetam in blood of patients with epilepsy","volume":"47","author":"PN Patsalos","year":"2006","journal-title":"Epilepsia"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/00007691-200312000-00007","article-title":"Serum concentrations of Levetiracetam in epileptic patients: the influence of dose and co-medication","volume":"25","author":"TW May","year":"2003","journal-title":"Ther Drug Monit"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s40262-013-0087-0","article-title":"Drug interactions with the newer antiepileptic drugs (AEDs)\u2013part 1: pharmacokinetic and pharmacodynamic interactions between AEDs","volume":"52","author":"PN Patsalos","year":"2013","journal-title":"Clin Pharmacokinet"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s40262-013-0088-z","article-title":"Drug interactions with the newer antiepileptic drugs (AEDs)\u2013Part 2: pharmacokinetic and pharmacodynamic interactions between AEDs and drugs used to treat non-epilepsy disorders","volume":"52","author":"PN Patsalos","year":"2013","journal-title":"Clin Pharmacokinet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/FTD.0b013e318157032d","article-title":"Therapeutic drug monitoring of levetiracetam by high-performance liquid chromatography with photodiode array ultraviolet detection: preliminary observations on correlation between plasma concentration and clinical response in patients with refractory epilepsy","volume":"29","author":"F Lancelin","year":"2007","journal-title":"Ther Drug Monit"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ebcr.2013.07.002","article-title":"Apparent dose-dependent levetiracetam-induced de novo major depression with suicidal behavior","volume":"1","author":"KR Kaufman","year":"2013","journal-title":"Epilepsy & Behavior Case Reports"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1528-1167.2008.01561.x","article-title":"Antiepileptic drugs\u2013best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies","author":"PN Patsalos","year":"2008","journal-title":"Epilepsia"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/FTD.0b013e3182048e05","article-title":"Performance characteristics of a new levetiracetam immunoassay and method comparison with a high-performance liquid chromatography method","volume":"33","author":"EZ Reineks","year":"2011","journal-title":"Ther Drug Monit"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jchromb.2013.02.005","article-title":"A simple bioanalytical method for the quantification of antiepileptic drugs in dried blood spots","volume":"923\u2013924","author":"NM Shah","year":"2013","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/chromsci\/bmr053","article-title":"Determination of ng\/mL levetiracetam using ultra-high-performance liquid chromatography-photodiode absorbance","volume":"50","author":"E Olah","year":"2012","journal-title":"J Chromatogr Sci"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jpba.2011.07.018","article-title":"Development and validation of an analytical method based on high performance thin layer chromatography for the simultaneous determination of lamotrigine, zonisamide and levetiracetam in human plasma","volume":"56","author":"L Antonilli","year":"2011","journal-title":"J Pharm Biomed Anal"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.clinbiochem.2009.10.014","article-title":"LC method for therapeutic drug monitoring of levetiracetam: evaluation of the assay performance and validation of its application in the routine area","volume":"43","author":"L Zufia","year":"2010","journal-title":"Clin Biochem"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jchromb.2008.08.007","article-title":"Simple and validated HPLC-UV analysis of levetiracetam in deproteinized plasma of patients with epilepsy","volume":"873","author":"M Contin","year":"2008","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/jat\/30.1.27","article-title":"Drug monitoring and toxicology: a procedure for the monitoring of levetiracetam and zonisamide by HPLC-UV","volume":"30","author":"J Juenke","year":"2006","journal-title":"J Anal Toxicol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jchromb.2005.01.040","article-title":"Determination of levetiracetam in human plasma with minimal sample pretreatment","volume":"819","author":"J Martens-Lobenhoffer","year":"2005","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/bmc.289","article-title":"High-performance liquid chromatographic determination of Levetiracetam in human plasma: comparison of different sample clean-up procedures","volume":"18","author":"V Pucci","year":"2004","journal-title":"Biomed Chromatogr"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00007691-200302000-00009","article-title":"Correlation of levetiracetam concentrations between serum and saliva","volume":"25","author":"SA Grim","year":"2003","journal-title":"Ther Drug Monit"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/00007691-199604000-00008","article-title":"A micromethod for the determination of the new antiepileptic drug levetiracetam (ucb LO59) in serum or plasma by high performance liquid chromatography","volume":"18","author":"N Ratnaraj","year":"1996","journal-title":"Ther Drug Monit"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0378-4347(94)00393-9","article-title":"High-performance liquid chromatographic and megabore gas-liquid chromatographic determination of levetiracetam (ucb L059) in human serum after solid-phase extraction","volume":"662","author":"TA Vermeij","year":"1994","journal-title":"J Chromatogr B Biomed Appl"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/jaoac\/93.4.1077","article-title":"Reversed-phase HPLC analysis of levetiracetam in tablets using monolithic and conventional C18 silica columns","volume":"93","author":"NO Can","year":"2010","journal-title":"J AOAC Int"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/FTD.0b013e3180683d55","article-title":"Saliva and serum levetiracetam concentrations in patients with epilepsy","volume":"29","author":"O Mecarelli","year":"2007","journal-title":"Ther Drug Monit"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0378-4347(00)00293-0","article-title":"Enantioselective analysis of levetiracetam and its enantiomer R-alpha-ethyl-2-oxo-pyrrolidine acetamide using gas chromatography and ion trap mass spectrometric detection","volume":"745","author":"N Isoherranen","year":"2000","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.clpt.2005.02.003","article-title":"Pharmacokinetics of levetiracetam in patients with moderate to severe liver cirrhosis (Child-Pugh classes A, B, and C): characterization by dynamic liver function tests","volume":"77","author":"J Brockmoller","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1528-1157.2003.25302.x","article-title":"Levetiracetam, a new antiepileptic agent: lack of in vitro and in vivo pharmacokinetic interaction with valproic acid","volume":"44","author":"R Coupez","year":"2003","journal-title":"Epilepsia"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/elps.200390143","article-title":"Microemulsion electrokinetic chromatography applied for separation of levetiracetam from other antiepileptic drugs in polypharmacy","volume":"24","author":"M Ivanova","year":"2003","journal-title":"Electrophoresis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.4155\/bio.13.143","article-title":"A simple assay for determination of levetiracetam in rat dried blood spots by LC-MS\/MS","volume":"5","author":"W Luo","year":"2013","journal-title":"Bioanalysis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/978-1-61779-934-1_18","article-title":"Analysis of selected anticonvulsants by high performance liquid chromatography-tandem mass spectrometry","volume":"902","author":"JA Collins","year":"2012","journal-title":"Methods Mol Biol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.clinbiochem.2009.11.008","article-title":"Simultaneous determination of levetiracetam and its acid metabolite (ucb L057) in serum\/plasma by liquid chromatography tandem mass spectrometry","volume":"43","author":"DR Mendu","year":"2010","journal-title":"Clin Biochem"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.jpba.2008.05.035","article-title":"Quantification of levetiracetam in human plasma by liquid chromatography-tandem mass spectrometry: application to therapeutic drug monitoring","volume":"48","author":"KM Matar","year":"2008","journal-title":"J Pharm Biomed Anal"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jpba.2011.07.019","article-title":"Simple and accurate quantitative analysis of ten antiepileptic drugs in human plasma by liquid chromatography\/tandem mass spectrometry","volume":"56","author":"KB Kim","year":"2011","journal-title":"J Pharm Biomed Anal"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cca.2006.06.022","article-title":"Determination of levetiracetam in human plasma\/serum\/saliva by liquid chromatography-electrospray tandem mass spectrometry","volume":"375","author":"T Guo","year":"2007","journal-title":"Clin Chim Acta"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1002\/rcm.2623","article-title":"Determination of levetiracetam in human plasma by liquid chromatography\/electrospray tandem mass spectrometry and its application to bioequivalence studies","volume":"20","author":"DS Jain","year":"2006","journal-title":"Rapid Commun Mass Spectrom"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.talanta.2013.02.010","article-title":"Fully validated method for rapid and simultaneous measurement of six antiepileptic drugs in serum and plasma using ultra-performance liquid chromatography-electrospray ionization tandem mass spectrometry","volume":"110","author":"J Kuhn","year":"2013","journal-title":"Talanta"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/bmc.2726","article-title":"Detection of 22 antiepileptic drugs by ultra-performance liquid chromatography coupled with tandem mass spectrometry applicable to routine therapeutic drug monitoring","volume":"26","author":"M Shibata","year":"2012","journal-title":"Biomed Chromatogr"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/FTD.0b013e31820b1fce","article-title":"Simultaneous quantification of levetiracetam and gabapentin in plasma by ultra-pressure liquid chromatography coupled with tandem mass spectrometry detection","volume":"33","author":"JM Juenke","year":"2011","journal-title":"Ther Drug Monit"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jchromb.2010.01.037","article-title":"Quantification of levetiracetam in plasma of neonates by ultra performance liquid chromatography-tandem mass spectrometry","volume":"878","author":"MI Blonk","year":"2010","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1046\/j.1528-1157.2001.41300.x","article-title":"Pharmacokinetic study of levetiracetam in children","volume":"42","author":"JM Pellock","year":"2001","journal-title":"Epilepsia"},{"key":"ref42","unstructured":"Food and Drug Administration Center for Drug Evaluation and Research (CDER) (2001) Guidance for industry: bioanalytical method validation. US Department of Health and Human Services. FDA Maryland."},{"key":"ref43","unstructured":"European Medicines Agency (2011) Guideline on bioanalytical method validation. EMA London."},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1111\/j.1528-1167.2007.01090.x","article-title":"Pharmacokinetics of levetiracetam in infants and young children with epilepsy","volume":"48","author":"TA Glauser","year":"2007","journal-title":"Epilepsia"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eplepsyres.2006.12.005","article-title":"Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproate","volume":"74","author":"NB Fountain","year":"2007","journal-title":"Epilepsy Res"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0111544","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T15:54:49Z","timestamp":1650556489000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0111544"}},"subtitle":[],"editor":[{"given":"Tony","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,11,6]]},"references-count":45,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2014,11,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0111544","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,6]]}}}